TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

NeOnc Technologies Holdings, Inc. Common Stock (NTHI)

Healthcare Biotechnology
3.50 $
+0.0% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns NeOnc Technologies Holdings, Inc. Common Stock (NTHI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 32.7% of the shares are freely tradable; institutional investors hold 11.1%.

Ownership Structure

Institutional ownership
11.1%
Insiders
58.5%
Float
32.7%
Short % of float
2.5%
Shares Outstanding
26Mio.

Largest Shareholders

Institutions

Institutions NTHI
Name Stake (%) Shares Change (%) Date
Cinctive Capital Management LP 5.48 1,425,526 +0.0 03/31/2026
Bank of America Corp 0.90 235,396 +5.0 03/31/2026
Vanguard Capital Management, LLC 0.83 215,700 +0.0 03/31/2026
Vanguard Group Inc 0.70 181,029 +28.5 12/31/2025
BlackRock Inc 0.60 155,838 -6.1 03/31/2026
Hudson Bay Capital Management LP 0.57 147,360 +0.0 03/31/2026
Geode Capital Management, LLC 0.49 126,853 +5.6 03/31/2026
Millennium Management LLC 0.46 119,249 +0.0 03/31/2026

Funds

Funds NTHI
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 0.51 131,454 +34.7 04/30/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.42 107,962 +0.0 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
10. Jul 2026 Shomali Nasim Director Other 50,000
23. Apr 2026 Amir F Heshmatpour President Buy 10,000 4.90 49,000
23. Apr 2026 Yousha Neman-Ebrahim Insider Buy 500 4.88 2,440

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?